# Lederle Arzneimittel · 66-66 · GERMANY — FDA import alert red lists: firms subject to detention without physical examination For Lederle Arzneimittel · 66-66 · GERMANY, import alert is 66-66; import alert name is "APIs That Appear To Be Misbranded Under 502(f)(1) Because They Do Not Meet The Requirements For The Labeling Exemptions In 21 CFR 201.122"; country is GERMANY; product is Calcium Leucovorin; product code is 61 C - S 01 Leucovorin Calcium (Anti-Anemic), Active Pharm Ingred/Chems for Further Manuf; date published is 09/30/2009; address is Schleebruggenkamp 15 , Munster, North Rhine-Westphalia GERMANY, verified against its source on 2026-09-16. - **Firm:** Lederle Arzneimittel _(verified: appears in the quote below)_ - **Import alert:** 66-66 - **Import alert name:** "APIs That Appear To Be Misbranded Under 502(f)(1) Because They Do Not Meet The Requirements For The Labeling Exemptions In 21 CFR 201.122" - **Country:** GERMANY _(verified: appears in the quote below)_ - **Address:** Schleebruggenkamp 15 , Munster, North Rhine-Westphalia GERMANY _(verified: appears in the quote below)_ - **Date published:** 09/30/2009 _(verified: appears in the quote below)_ - **Product code:** 61 C - S 01 Leucovorin Calcium (Anti-Anemic), Active Pharm Ingred/Chems for Further Manuf _(verified: appears in the quote below)_ - **Product:** Calcium Leucovorin _(verified: appears in the quote below)_ - **FDA notes:** 11/2/2000 _(verified: appears in the quote below)_ ## What the source says > Lederle Arzneimittel Date Published : 09/30/2009 Schleebruggenkamp 15 , Munster, North Rhine-Westphalia GERMANY 61 C - S 01 Leucovorin Calcium (Anti-Anemic), Active Pharm Ingred/Chems for Further Manuf Date Published: 03/29/2019 Desc: Calcium Leucovorin Notes: 11/2/2000 ## Source - https://www.accessdata.fda.gov/cms_ia/importalert_202.html Last verified: 2026-09-16. Review by: 2026-11-15. Part of [FDA import alert red lists: firms subject to detention without physical examination](https://referencesource.org/fda-import-alert-red-list/).